Recombinant HLA-DRA antibody
-
- Target See all HLA-DRA Antibodies
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
- Antibody Type
- Recombinant Antibody
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Monoclonal
-
Conjugate
- This HLA-DRA antibody is un-conjugated
-
Application
- Immunohistochemistry (IHC)
- Clone
- MSVA-470R
- Isotype
- IgG
- Top Product
- Discover our top product HLA-DRA Primary Antibody
-
-
- Application Notes
- IHC 1:100-1:200
- Comment
-
Positive Control: Liver: An at least moderate staining should be seen of sinusoids and Kupffer cells. Kidney: An at least moderate staining should be seen in small capillaries of glomeruli.
Negative Control: Absence of HLA-DRa staining is expected in hepatocytes of a completely normal liver and in tubuli of completely normal kidney.
- Protocol
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Storage
- 4 °C,-20 °C,-80 °C
- Storage Comment
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
- Target
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
- Alternative Name
- HLA-DRa (HLA-DRA Products)
- Synonyms
- HLA-DRA1 antibody, MLRW antibody, DR-alpha antibody, HLA-DRA antibody, Mamu-DRA1 antibody, major histocompatibility complex, class II, DR alpha L homeolog antibody, major histocompatibility complex, class II, DR alpha antibody, hla-dra.L antibody, HLA-DRA antibody, MAMU-DRA antibody, BOLA-DRA antibody
- Background
- DR alpha chain, DRB1, DRB4, HLA class II histocompatibility antigen DR alpha chain, HLA DR1B, HLA DR3B, HLA DRA, HLA-DRA, HLADR4B, HLADRA1, HLADRB, Major histocompatibility complex class II DR alpha, Major histocompatibility complex class II DR beta 1/3/4/5,HLA-DRa antibody validated for immunohistochemistry on 76 different Normal Tissues
- UniProt
- P01903
- Pathways
- TCR Signaling, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-